Update on biomarkers for the detection of lung cancer
Eloisa Jantus-Lewintre,1 Marta Usó,1 Elena Sanmartín,1 Carlos Camps,1–31Molecular Oncology Laboratory, Fundación para la Investigación del Hospital General Universitario, Valencia, Spain; 2Deparment of Medical Oncology, Consor...
Guardado en:
Autores principales: | Jantus-Lewintre E, Usó M, Sanmartín E, Camps C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/53dc1c85a5444400933640083c98ec45 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study
por: Pascual T, et al.
Publicado: (2012) -
Population-based service mammography screening: the Icelandic experience
por: Sigurdsson K, et al.
Publicado: (2013) -
Non-small cell lung cancer: the era of targeted therapy
por: Antonoff MB, et al.
Publicado: (2012) -
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Michelle R. Goulart, et al.
Publicado: (2021) -
Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis
por: Ke Gong MBBS, et al.
Publicado: (2021)